CPI-300 is a drug that has been developed by IntelGenx Corp. (NASDAQ:IGXT.OB) and its partner, Cary Pharmaceuticals, Inc, under the Collaborative Agreement signed by the two companies in 2007. The drug is used as an …
Most families these days feel like they can barely make ends meet, never mind have anything left in their wallet to invest. The first step toward financial freedom is cutting expenses below your income. In …